Literature DB >> 16867900

Induction of erythroid-specific genes by overexpression of GATA-2 in K562 cells.

Hideo Harigae1, Yoko Okitsu, Hisayuki Yokoyama, Tohru Fujiwara, Mitsue Inomata, Shinichiro Takahashi, Naoko Minegishi, Mitsuo Kaku, Takeshi Sasaki.   

Abstract

GATA transcription factors have been shown to play important roles in hematopoiesis. GATA-2 is expressed in stem and progenitor cells, and has been speculated to control the proliferation and maintain the immaturity of these cells. To examine whether the function of GATA-2 is changeable according to the differentiation stage, we established GATA-2 overexpressing subclones of K562, which is a leukemic cell line committed to the erythroid lineage. Via an increase in the GATA-2 expression level, the expression levels of erythroid-specific genes including alpha-, beta-, and gamma-globin were increased compared to control cells, while the expression level of GATA-1 was unchanged. Expression of the transferrin receptor was also increased in GATA-2 overexpressing K562 cells when examined by flow cytometry. In addition, the heme content of GATA-2 overexpressing K562 cells was more than 2 times higher than control cells. Chromatin immunoprecipitation analysis showed that GATA-2 protein binding to the GATA element in alpha-globin LCR was increased in GATA-2 overexpressing K562 cells. These findings suggest that GATA-2 could induce erythroid-specific genes without competition with GATA-1 when expressed in erythroid-committed cells, and thus further suggest that temporal and spatial regulation may be important for displaying specific functions of GATA-2.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16867900     DOI: 10.1532/IJH97.06020

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  25 in total

1.  Functional overlap of GATA-1 and GATA-2 in primitive hematopoietic development.

Authors:  Yuko Fujiwara; Aaron N Chang; Aimee M Williams; Stuart H Orkin
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

2.  Activity and tissue-specific expression of the transcription factor NF-E1 multigene family.

Authors:  M Yamamoto; L J Ko; M W Leonard; H Beug; S H Orkin; J D Engel
Journal:  Genes Dev       Date:  1990-10       Impact factor: 11.361

3.  Rapid turnover of GATA-2 via ubiquitin-proteasome protein degradation pathway.

Authors:  Naoko Minegishi; Norio Suzuki; Yukie Kawatani; Ritsuko Shimizu; Masayuki Yamamoto
Journal:  Genes Cells       Date:  2005-07       Impact factor: 1.891

4.  Decreased expression of transcription factor GATA-2 in haematopoietic stem cells in patients with aplastic anaemia.

Authors:  S Fujimaki; H Harigae; T Sugawara; N Takasawa; T Sasaki; M Kaku
Journal:  Br J Haematol       Date:  2001-04       Impact factor: 6.998

5.  Redirecting differentiation of hematopoietic progenitors by a transcription factor, GATA-2.

Authors:  Kenji Kitajima; Makoto Tanaka; Jie Zheng; Hilo Yen; Ayuko Sato; Daijiro Sugiyama; Hiroki Umehara; Eiko Sakai; Toru Nakano
Journal:  Blood       Date:  2005-10-27       Impact factor: 22.113

6.  Overexpression of GATA-2 inhibits erythroid and promotes megakaryocyte differentiation.

Authors:  P Ikonomi; C E Rivera; M Riordan; G Washington; A N Schechter; C T Noguchi
Journal:  Exp Hematol       Date:  2000-12       Impact factor: 3.084

7.  Alternative promoters regulate transcription of the mouse GATA-2 gene.

Authors:  N Minegishi; J Ohta; N Suwabe; H Nakauchi; H Ishihara; N Hayashi; M Yamamoto
Journal:  J Biol Chem       Date:  1998-02-06       Impact factor: 5.157

8.  Heme regulates the dynamic exchange of Bach1 and NF-E2-related factors in the Maf transcription factor network.

Authors:  Jiying Sun; Marjorie Brand; Yukari Zenke; Satoshi Tashiro; Mark Groudine; Kazuhiko Igarashi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-27       Impact factor: 11.205

9.  Aberrant iron accumulation and oxidized status of erythroid-specific delta-aminolevulinate synthase (ALAS2)-deficient definitive erythroblasts.

Authors:  Hideo Harigae; Osamu Nakajima; Naruyoshi Suwabe; Hisayuki Yokoyama; Kazumichi Furuyama; Takeshi Sasaki; Mitsuo Kaku; Masayuki Yamamoto; Shigeru Sassa
Journal:  Blood       Date:  2002-10-03       Impact factor: 22.113

10.  An early haematopoietic defect in mice lacking the transcription factor GATA-2.

Authors:  F Y Tsai; G Keller; F C Kuo; M Weiss; J Chen; M Rosenblatt; F W Alt; S H Orkin
Journal:  Nature       Date:  1994-09-15       Impact factor: 49.962

View more
  5 in total

1.  Dynamic transcription factor activity profiles reveal key regulatory interactions during megakaryocytic and erythroid differentiation.

Authors:  Mark T Duncan; Seungjin Shin; Jia J Wu; Zachary Mays; Stanley Weng; Neda Bagheri; William M Miller; Lonnie D Shea
Journal:  Biotechnol Bioeng       Date:  2014-07-14       Impact factor: 4.530

2.  Cdc42 critically regulates the balance between myelopoiesis and erythropoiesis.

Authors:  Linda Yang; Lei Wang; Theodosia A Kalfa; Jose A Cancelas; Xun Shang; Suvarnamala Pushkaran; Jun Mo; David A Williams; Yi Zheng
Journal:  Blood       Date:  2007-08-16       Impact factor: 22.113

3.  Gene expression profiling identifies HOXB4 as a direct downstream target of GATA-2 in human CD34+ hematopoietic cells.

Authors:  Tohru Fujiwara; Hisayuki Yokoyama; Yoko Okitsu; Mayumi Kamata; Noriko Fukuhara; Yasushi Onishi; Shinichi Fujimaki; Shinichiro Takahashi; Kenichi Ishizawa; Emery H Bresnick; Hideo Harigae
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

4.  Characterization of the transcriptome profiles related to globin gene switching during in vitro erythroid maturation.

Authors:  Biaoru Li; Lianghao Ding; Wei Li; Michael D Story; Betty S Pace
Journal:  BMC Genomics       Date:  2012-04-26       Impact factor: 3.969

5.  C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells.

Authors:  Eleonora Brognara; Ilaria Lampronti; Giulia Breveglieri; Alessandro Accetta; Roberto Corradini; Alex Manicardi; Monica Borgatti; Alessandro Canella; Chiara Multineddu; Rosangela Marchelli; Roberto Gambari
Journal:  Eur J Pharmacol       Date:  2011-09-21       Impact factor: 4.432

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.